Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
The reported figure is also narrower than the Zacks Consensus Estimate of a loss of 19 cents per share. Revenues Revenues reported in the first quarter increased 17.5% year over year to $96.8 million. The metric exceeded the Zacks Consensus Estimate by 3.3%. Quarterly Details Testing revenues were $90.3 million in the reported quarter, up 24.7% year over year. This rise was mainly due to Decipher and Affirma volumes, along with ASP (Average Selling Price) growth, driven by payer contracting and prior period collection. Product revenues fell 9.1% year over year to $3.5 million. Veracyte, Inc. Price, Consensus and EPS Surprise Veracyte, Inc. price-consensus-eps-surprise-chart | Veracyte, Inc. Quote Biopharmaceutical and other revenues of $3.0 million reflected a 51% decrease compared to last year's figure. This was mainly affected by the overall spending constraints across the industry. Margins The total cost of revenues (product, testing, biopharmaceutical and other
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Veracyte to Participate in Upcoming Investor ConferencesBusiness Wire
- Wall Street Analysts Believe Veracyte (VCYT) Could Rally 39.59%: Here's is How to Trade [Yahoo! Finance]Yahoo! Finance
- Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount? [Yahoo! Finance]Yahoo! Finance
- Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Veracyte, Inc. (NASDAQ: VCYT) had its price target lowered by analysts at Needham & Company LLC from $33.00 to $27.00. They now have a "buy" rating on the stock.MarketBeat
VCYT
Earnings
- 5/7/24 - Beat
VCYT
Sec Filings
- 5/8/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 4/25/24 - Form ARS
- VCYT's page on the SEC website